← Back to Clinical Trials
Recruiting NCT07624500

NCT07624500 Food and Metabolism Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07624500
Status Recruiting
Phase
Sponsor Clinical Nutrition Research Center, Illinois Institute of Technology
Condition Prediabetes
Study Type INTERVENTIONAL
Enrollment 82 participants
Start Date 2026-06-03
Primary Completion 2027-06-28

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Avocado meal planControl meal plan

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 82 participants in total. It began in 2026-06-03 with a primary completion date of 2027-06-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this study, Investigators are interested in looking at the influence of eating avocados regularly, which are rich in healthy fats, fibers, and unique carbohydrates, on triglyceride and glucose metabolism in people with prediabetes and insulin resistance.

Eligibility Criteria

Inclusion Criteria: * Men or women, 40-70 years of age. * Fasting triglycerides (TG) \>115 mg/dL. * Insulin resistance as measured by Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) \>2.5. * Able to provide informed consent. * Able to comply with and perform the procedures requested by the protocol, specifically eat all the meals and snacks provided by the study which will be almost all your food (\~ 80% of calories per day). * Able to come to the clinic up to 6 times during the study. * Able to maintain usual physical activity pattern. * Able to avoid/abstain from alcohol and vigorous physical activity for 24 hours prior to and during study visit. Exclusion Criteria: * Men and women with known or suspected intolerance, allergies or hypersensitivity to study foods or interventions. * Fasting blood sugar ≥125 mg/dL. Men and women with blood pressure \>160 mmHg (systolic) / 100 mmHg (diastolic) at the screening visit. * Men and women with history of diabetes cardiovascular events, respiratory, renal, gastrointestinal, hepatic or eye disease or surgery- within a year. * Men and women who have or had cancer other than non-melanoma skin cancer in the past 5 years. * Men and women taking over the counter or prescription medications or dietary supplements that may interfere with study procedures or endpoints. * Men and women who are on a specialized diet (vegan, vegetarian, keto, etc.). - - Men and women who consume nuts or peanuts daily or most days of the week. * Men and women who are not weight stable (+/-10lbs in previous 2 months). Men and women who have excessive use of drugs or alcohol (ie., addictions) within the past 2 years. * Men and women with documented physical or mental disease/condition, which might limit participation in or completion of the study or, that, in the opinion of the investigator, could interfere with the interpretation of the study results. * Women who are known to be pregnant or who are intending to become pregnant over the course of the study. * Women who are lactating. * Major trauma or a surgical event within 2 months (or longer depending on trauma or event) and after consultation with PI. Has used antibiotics within the previous 2 months. * History of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, or binge eating) diagnosed by a health professional. * Excessive coffee and tea consumers (\> 4 cups/d). * Donated blood within the last 3 months. * Women who are taking an unstable dose and brand of hormonal contraceptives and/or a stable dose and brand for less than 6 months. * Unusual working hours (working overnight).

Contact & Investigator

Central Contact

Chelsea Preiss, MS

✉ cpreiss@illinoistech.edu

📞 312-567-5300

Principal Investigator

Britt Burton-Freeman, PhD

PRINCIPAL INVESTIGATOR

Food Sci and Nut Programs

Frequently Asked Questions

Who can join the NCT07624500 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Prediabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07624500 currently recruiting?

Yes, NCT07624500 is actively recruiting participants. Contact the research team at cpreiss@illinoistech.edu for enrollment information.

Where is the NCT07624500 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT07624500 clinical trial?

NCT07624500 is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology. The principal investigator is Britt Burton-Freeman, PhD at Food Sci and Nut Programs. The trial plans to enroll 82 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology